MCAM and cutaneous melanoma: We confirmed that MCAM and CHAF1B were overexpressed compared to the healthy melanocyte cell line (NHEM) in both the commercial cutaneous melanoma cell line (A375) and short-term cutaneous and nodal metastatic melanoma cell lines (LM-36 and LM-16, respectively).